Global Tuberculosis Prevention and Treatment Vaccine Market Research Report 2026(Status and Outlook)
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Gu?rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Tuberculosis Prevention and Treatment Vaccine market size was estimated at USD 81.1 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Tuberculosis Prevention and Treatment Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Tuberculosis Prevention and Treatment Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Tuberculosis Prevention and Treatment Vaccine market.
Global Tuberculosis Prevention and Treatment Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Market Segmentation (by Type)
Immune Vaccine
Therapy Vaccine
Market Segmentation (by Application)
Self-Procurement
UNICEF
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Tuberculosis Prevention and Treatment Vaccine Market
Overview of the regional outlook of the Tuberculosis Prevention and Treatment Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tuberculosis Prevention and Treatment Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Tuberculosis Prevention and Treatment Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Tuberculosis Prevention and Treatment Vaccine market size was estimated at USD 81.1 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Tuberculosis Prevention and Treatment Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Tuberculosis Prevention and Treatment Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Tuberculosis Prevention and Treatment Vaccine market.
Global Tuberculosis Prevention and Treatment Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Market Segmentation (by Type)
Immune Vaccine
Therapy Vaccine
Market Segmentation (by Application)
Self-Procurement
UNICEF
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Tuberculosis Prevention and Treatment Vaccine Market
Overview of the regional outlook of the Tuberculosis Prevention and Treatment Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tuberculosis Prevention and Treatment Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Tuberculosis Prevention and Treatment Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Tuberculosis Prevention and Treatment Vaccine
1.2 Key Market Segments
1.2.1 Tuberculosis Prevention and Treatment Vaccine Segment by Type
1.2.2 Tuberculosis Prevention and Treatment Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Tuberculosis Prevention and Treatment Vaccine Product Life Cycle
3.3 Global Tuberculosis Prevention and Treatment Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Tuberculosis Prevention and Treatment Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Tuberculosis Prevention and Treatment Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Tuberculosis Prevention and Treatment Vaccine Market Competitive Situation and Trends
3.8.1 Tuberculosis Prevention and Treatment Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Tuberculosis Prevention and Treatment Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Tuberculosis Prevention and Treatment Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Tuberculosis Prevention and Treatment Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Tuberculosis Prevention and Treatment Vaccine Market
5.7 ESG Ratings of Leading Companies
6 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Tuberculosis Prevention and Treatment Vaccine Market Size by Type (2020-2025)
6.4 Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2020-2025)
7 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tuberculosis Prevention and Treatment Vaccine Market Sales by Application (2020-2025)
7.3 Global Tuberculosis Prevention and Treatment Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Tuberculosis Prevention and Treatment Vaccine Sales Growth Rate by Application (2020-2025)
8 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET SALES BY REGION
8.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Region
8.1.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Region
8.1.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region
8.2 Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region
8.2.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region
8.2.2 Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region
8.3 North America
8.3.1 North America Tuberculosis Prevention and Treatment Vaccine Sales by Country
8.3.2 North America Tuberculosis Prevention and Treatment Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country
8.4.2 Europe Tuberculosis Prevention and Treatment Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Region
8.5.2 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Tuberculosis Prevention and Treatment Vaccine Sales by Country
8.6.2 South America Tuberculosis Prevention and Treatment Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales by Region
8.7.2 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Tuberculosis Prevention and Treatment Vaccine by Region(2020-2025)
9.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Tuberculosis Prevention and Treatment Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Tuberculosis Prevention and Treatment Vaccine Production
9.4.1 North America Tuberculosis Prevention and Treatment Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Tuberculosis Prevention and Treatment Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Tuberculosis Prevention and Treatment Vaccine Production
9.5.1 Europe Tuberculosis Prevention and Treatment Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Tuberculosis Prevention and Treatment Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Tuberculosis Prevention and Treatment Vaccine Production (2020-2025)
9.6.1 Japan Tuberculosis Prevention and Treatment Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Tuberculosis Prevention and Treatment Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Tuberculosis Prevention and Treatment Vaccine Production (2020-2025)
9.7.1 China Tuberculosis Prevention and Treatment Vaccine Production Growth Rate (2020-2025)
9.7.2 China Tuberculosis Prevention and Treatment Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Tuberculosis Prevention and Treatment Vaccine Product Overview
10.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Japan BCG Lab
10.2.1 Japan BCG Lab Basic Information
10.2.2 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Overview
10.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.2.4 Japan BCG Lab Business Overview
10.2.5 Japan BCG Lab SWOT Analysis
10.2.6 Japan BCG Lab Recent Developments
10.3 Serum Institute of India
10.3.1 Serum Institute of India Basic Information
10.3.2 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Overview
10.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.3.4 Serum Institute of India Business Overview
10.3.5 Serum Institute of India SWOT Analysis
10.3.6 Serum Institute of India Recent Developments
10.4 AJ Vaccines
10.4.1 AJ Vaccines Basic Information
10.4.2 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Overview
10.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.4.4 AJ Vaccines Business Overview
10.4.5 AJ Vaccines Recent Developments
10.5 BioFarma
10.5.1 BioFarma Basic Information
10.5.2 BioFarma Tuberculosis Prevention and Treatment Vaccine Product Overview
10.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.5.4 BioFarma Business Overview
10.5.5 BioFarma Recent Developments
10.6 GreenSignal Bio Pharma
10.6.1 GreenSignal Bio Pharma Basic Information
10.6.2 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Overview
10.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.6.4 GreenSignal Bio Pharma Business Overview
10.6.5 GreenSignal Bio Pharma Recent Developments
10.7 China National Biotec
10.7.1 China National Biotec Basic Information
10.7.2 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Overview
10.7.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.7.4 China National Biotec Business Overview
10.7.5 China National Biotec Recent Developments
10.8 Biomed Lublin
10.8.1 Biomed Lublin Basic Information
10.8.2 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Overview
10.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.8.4 Biomed Lublin Business Overview
10.8.5 Biomed Lublin Recent Developments
10.9 Taj Pharmaceuticals
10.9.1 Taj Pharmaceuticals Basic Information
10.9.2 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Overview
10.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.9.4 Taj Pharmaceuticals Business Overview
10.9.5 Taj Pharmaceuticals Recent Developments
10.10 Ataulpho de Paiva
10.10.1 Ataulpho de Paiva Basic Information
10.10.2 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Overview
10.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.10.4 Ataulpho de Paiva Business Overview
10.10.5 Ataulpho de Paiva Recent Developments
10.11 IVAC
10.11.1 IVAC Basic Information
10.11.2 IVAC Tuberculosis Prevention and Treatment Vaccine Product Overview
10.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.11.4 IVAC Business Overview
10.11.5 IVAC Recent Developments
10.12 Queen Saovabha Mem. Inst
10.12.1 Queen Saovabha Mem. Inst Basic Information
10.12.2 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Overview
10.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.12.4 Queen Saovabha Mem. Inst Business Overview
10.12.5 Queen Saovabha Mem. Inst Recent Developments
10.13 Microgen
10.13.1 Microgen Basic Information
10.13.2 Microgen Tuberculosis Prevention and Treatment Vaccine Product Overview
10.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.13.4 Microgen Business Overview
10.13.5 Microgen Recent Developments
11 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET FORECAST BY REGION
11.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast
11.2 Global Tuberculosis Prevention and Treatment Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Region
11.2.4 South America Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Tuberculosis Prevention and Treatment Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Tuberculosis Prevention and Treatment Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Tuberculosis Prevention and Treatment Vaccine by Type (2026-2035)
12.1.2 Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Tuberculosis Prevention and Treatment Vaccine by Type (2026-2035)
12.2 Global Tuberculosis Prevention and Treatment Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Tuberculosis Prevention and Treatment Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Tuberculosis Prevention and Treatment Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Tuberculosis Prevention and Treatment Vaccine
1.2 Key Market Segments
1.2.1 Tuberculosis Prevention and Treatment Vaccine Segment by Type
1.2.2 Tuberculosis Prevention and Treatment Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Tuberculosis Prevention and Treatment Vaccine Product Life Cycle
3.3 Global Tuberculosis Prevention and Treatment Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Tuberculosis Prevention and Treatment Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Tuberculosis Prevention and Treatment Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Tuberculosis Prevention and Treatment Vaccine Market Competitive Situation and Trends
3.8.1 Tuberculosis Prevention and Treatment Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Tuberculosis Prevention and Treatment Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Tuberculosis Prevention and Treatment Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Tuberculosis Prevention and Treatment Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Tuberculosis Prevention and Treatment Vaccine Market
5.7 ESG Ratings of Leading Companies
6 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Tuberculosis Prevention and Treatment Vaccine Market Size by Type (2020-2025)
6.4 Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2020-2025)
7 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tuberculosis Prevention and Treatment Vaccine Market Sales by Application (2020-2025)
7.3 Global Tuberculosis Prevention and Treatment Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Tuberculosis Prevention and Treatment Vaccine Sales Growth Rate by Application (2020-2025)
8 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET SALES BY REGION
8.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Region
8.1.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Region
8.1.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region
8.2 Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region
8.2.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region
8.2.2 Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region
8.3 North America
8.3.1 North America Tuberculosis Prevention and Treatment Vaccine Sales by Country
8.3.2 North America Tuberculosis Prevention and Treatment Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country
8.4.2 Europe Tuberculosis Prevention and Treatment Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Region
8.5.2 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Tuberculosis Prevention and Treatment Vaccine Sales by Country
8.6.2 South America Tuberculosis Prevention and Treatment Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales by Region
8.7.2 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Tuberculosis Prevention and Treatment Vaccine by Region(2020-2025)
9.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Tuberculosis Prevention and Treatment Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Tuberculosis Prevention and Treatment Vaccine Production
9.4.1 North America Tuberculosis Prevention and Treatment Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Tuberculosis Prevention and Treatment Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Tuberculosis Prevention and Treatment Vaccine Production
9.5.1 Europe Tuberculosis Prevention and Treatment Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Tuberculosis Prevention and Treatment Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Tuberculosis Prevention and Treatment Vaccine Production (2020-2025)
9.6.1 Japan Tuberculosis Prevention and Treatment Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Tuberculosis Prevention and Treatment Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Tuberculosis Prevention and Treatment Vaccine Production (2020-2025)
9.7.1 China Tuberculosis Prevention and Treatment Vaccine Production Growth Rate (2020-2025)
9.7.2 China Tuberculosis Prevention and Treatment Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Tuberculosis Prevention and Treatment Vaccine Product Overview
10.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Japan BCG Lab
10.2.1 Japan BCG Lab Basic Information
10.2.2 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Overview
10.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.2.4 Japan BCG Lab Business Overview
10.2.5 Japan BCG Lab SWOT Analysis
10.2.6 Japan BCG Lab Recent Developments
10.3 Serum Institute of India
10.3.1 Serum Institute of India Basic Information
10.3.2 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Overview
10.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.3.4 Serum Institute of India Business Overview
10.3.5 Serum Institute of India SWOT Analysis
10.3.6 Serum Institute of India Recent Developments
10.4 AJ Vaccines
10.4.1 AJ Vaccines Basic Information
10.4.2 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Overview
10.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.4.4 AJ Vaccines Business Overview
10.4.5 AJ Vaccines Recent Developments
10.5 BioFarma
10.5.1 BioFarma Basic Information
10.5.2 BioFarma Tuberculosis Prevention and Treatment Vaccine Product Overview
10.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.5.4 BioFarma Business Overview
10.5.5 BioFarma Recent Developments
10.6 GreenSignal Bio Pharma
10.6.1 GreenSignal Bio Pharma Basic Information
10.6.2 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Overview
10.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.6.4 GreenSignal Bio Pharma Business Overview
10.6.5 GreenSignal Bio Pharma Recent Developments
10.7 China National Biotec
10.7.1 China National Biotec Basic Information
10.7.2 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Overview
10.7.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.7.4 China National Biotec Business Overview
10.7.5 China National Biotec Recent Developments
10.8 Biomed Lublin
10.8.1 Biomed Lublin Basic Information
10.8.2 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Overview
10.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.8.4 Biomed Lublin Business Overview
10.8.5 Biomed Lublin Recent Developments
10.9 Taj Pharmaceuticals
10.9.1 Taj Pharmaceuticals Basic Information
10.9.2 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Overview
10.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.9.4 Taj Pharmaceuticals Business Overview
10.9.5 Taj Pharmaceuticals Recent Developments
10.10 Ataulpho de Paiva
10.10.1 Ataulpho de Paiva Basic Information
10.10.2 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Overview
10.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.10.4 Ataulpho de Paiva Business Overview
10.10.5 Ataulpho de Paiva Recent Developments
10.11 IVAC
10.11.1 IVAC Basic Information
10.11.2 IVAC Tuberculosis Prevention and Treatment Vaccine Product Overview
10.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.11.4 IVAC Business Overview
10.11.5 IVAC Recent Developments
10.12 Queen Saovabha Mem. Inst
10.12.1 Queen Saovabha Mem. Inst Basic Information
10.12.2 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Overview
10.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.12.4 Queen Saovabha Mem. Inst Business Overview
10.12.5 Queen Saovabha Mem. Inst Recent Developments
10.13 Microgen
10.13.1 Microgen Basic Information
10.13.2 Microgen Tuberculosis Prevention and Treatment Vaccine Product Overview
10.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Product Market Performance
10.13.4 Microgen Business Overview
10.13.5 Microgen Recent Developments
11 TUBERCULOSIS PREVENTION AND TREATMENT VACCINE MARKET FORECAST BY REGION
11.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast
11.2 Global Tuberculosis Prevention and Treatment Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Region
11.2.4 South America Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Tuberculosis Prevention and Treatment Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Tuberculosis Prevention and Treatment Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Tuberculosis Prevention and Treatment Vaccine by Type (2026-2035)
12.1.2 Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Tuberculosis Prevention and Treatment Vaccine by Type (2026-2035)
12.2 Global Tuberculosis Prevention and Treatment Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Tuberculosis Prevention and Treatment Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Tuberculosis Prevention and Treatment Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Type (M USD)
Table 4. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Application
Table 5. Tuberculosis Prevention and Treatment Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Tuberculosis Prevention and Treatment Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Tuberculosis Prevention and Treatment Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Tuberculosis Prevention and Treatment Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Prevention and Treatment Vaccine as of 2025)
Table 11. Global Market Tuberculosis Prevention and Treatment Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Tuberculosis Prevention and Treatment Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tuberculosis Prevention and Treatment Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (K MT)
Table 27. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Type (M USD)
Table 28. Global Tuberculosis Prevention and Treatment Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Tuberculosis Prevention and Treatment Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Type (2020-2025)
Table 32. Global Tuberculosis Prevention and Treatment Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Tuberculosis Prevention and Treatment Vaccine Sales (K MT) by Application
Table 34. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Application
Table 35. Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Application (2020-2025)
Table 39. Global Tuberculosis Prevention and Treatment Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Tuberculosis Prevention and Treatment Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region (2020-2025)
Table 44. North America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Tuberculosis Prevention and Treatment Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Tuberculosis Prevention and Treatment Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Tuberculosis Prevention and Treatment Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Tuberculosis Prevention and Treatment Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Tuberculosis Prevention and Treatment Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Tuberculosis Prevention and Treatment Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Tuberculosis Prevention and Treatment Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Tuberculosis Prevention and Treatment Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Tuberculosis Prevention and Treatment Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck Basic Information
Table 63. Merck Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 64. Merck Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck Business Overview
Table 66. Merck SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Japan BCG Lab Basic Information
Table 69. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 70. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Japan BCG Lab Business Overview
Table 72. Japan BCG Lab SWOT Analysis
Table 73. Japan BCG Lab Recent Developments
Table 74. Serum Institute of India Basic Information
Table 75. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 76. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Serum Institute of India Business Overview
Table 78. Serum Institute of India SWOT Analysis
Table 79. Serum Institute of India Recent Developments
Table 80. AJ Vaccines Basic Information
Table 81. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 82. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. AJ Vaccines Business Overview
Table 84. AJ Vaccines Recent Developments
Table 85. BioFarma Basic Information
Table 86. BioFarma Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 87. BioFarma Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. BioFarma Business Overview
Table 89. BioFarma Recent Developments
Table 90. GreenSignal Bio Pharma Basic Information
Table 91. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 92. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. GreenSignal Bio Pharma Business Overview
Table 94. GreenSignal Bio Pharma Recent Developments
Table 95. China National Biotec Basic Information
Table 96. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 97. China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. China National Biotec Business Overview
Table 99. China National Biotec Recent Developments
Table 100. Biomed Lublin Basic Information
Table 101. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 102. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Biomed Lublin Business Overview
Table 104. Biomed Lublin Recent Developments
Table 105. Taj Pharmaceuticals Basic Information
Table 106. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 107. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Taj Pharmaceuticals Business Overview
Table 109. Taj Pharmaceuticals Recent Developments
Table 110. Ataulpho de Paiva Basic Information
Table 111. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 112. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Ataulpho de Paiva Business Overview
Table 114. Ataulpho de Paiva Recent Developments
Table 115. IVAC Basic Information
Table 116. IVAC Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 117. IVAC Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. IVAC Business Overview
Table 119. IVAC Recent Developments
Table 120. Queen Saovabha Mem. Inst Basic Information
Table 121. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 122. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Queen Saovabha Mem. Inst Business Overview
Table 124. Queen Saovabha Mem. Inst Recent Developments
Table 125. Microgen Basic Information
Table 126. Microgen Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 127. Microgen Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Microgen Business Overview
Table 129. Microgen Recent Developments
Table 130. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 131. Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 133. North America Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 135. Europe Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 137. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 139. South America Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 143. Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Tuberculosis Prevention and Treatment Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 145. Global Tuberculosis Prevention and Treatment Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 146. Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Type (M USD)
Table 4. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Application
Table 5. Tuberculosis Prevention and Treatment Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Tuberculosis Prevention and Treatment Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Tuberculosis Prevention and Treatment Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Tuberculosis Prevention and Treatment Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Prevention and Treatment Vaccine as of 2025)
Table 11. Global Market Tuberculosis Prevention and Treatment Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Tuberculosis Prevention and Treatment Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tuberculosis Prevention and Treatment Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (K MT)
Table 27. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Type (M USD)
Table 28. Global Tuberculosis Prevention and Treatment Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Tuberculosis Prevention and Treatment Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Type (2020-2025)
Table 32. Global Tuberculosis Prevention and Treatment Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Tuberculosis Prevention and Treatment Vaccine Sales (K MT) by Application
Table 34. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Application
Table 35. Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Application (2020-2025)
Table 39. Global Tuberculosis Prevention and Treatment Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Tuberculosis Prevention and Treatment Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region (2020-2025)
Table 44. North America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Tuberculosis Prevention and Treatment Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Tuberculosis Prevention and Treatment Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Tuberculosis Prevention and Treatment Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Tuberculosis Prevention and Treatment Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Tuberculosis Prevention and Treatment Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Tuberculosis Prevention and Treatment Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Tuberculosis Prevention and Treatment Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Tuberculosis Prevention and Treatment Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Tuberculosis Prevention and Treatment Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck Basic Information
Table 63. Merck Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 64. Merck Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck Business Overview
Table 66. Merck SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Japan BCG Lab Basic Information
Table 69. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 70. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Japan BCG Lab Business Overview
Table 72. Japan BCG Lab SWOT Analysis
Table 73. Japan BCG Lab Recent Developments
Table 74. Serum Institute of India Basic Information
Table 75. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 76. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Serum Institute of India Business Overview
Table 78. Serum Institute of India SWOT Analysis
Table 79. Serum Institute of India Recent Developments
Table 80. AJ Vaccines Basic Information
Table 81. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 82. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. AJ Vaccines Business Overview
Table 84. AJ Vaccines Recent Developments
Table 85. BioFarma Basic Information
Table 86. BioFarma Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 87. BioFarma Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. BioFarma Business Overview
Table 89. BioFarma Recent Developments
Table 90. GreenSignal Bio Pharma Basic Information
Table 91. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 92. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. GreenSignal Bio Pharma Business Overview
Table 94. GreenSignal Bio Pharma Recent Developments
Table 95. China National Biotec Basic Information
Table 96. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 97. China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. China National Biotec Business Overview
Table 99. China National Biotec Recent Developments
Table 100. Biomed Lublin Basic Information
Table 101. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 102. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Biomed Lublin Business Overview
Table 104. Biomed Lublin Recent Developments
Table 105. Taj Pharmaceuticals Basic Information
Table 106. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 107. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Taj Pharmaceuticals Business Overview
Table 109. Taj Pharmaceuticals Recent Developments
Table 110. Ataulpho de Paiva Basic Information
Table 111. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 112. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Ataulpho de Paiva Business Overview
Table 114. Ataulpho de Paiva Recent Developments
Table 115. IVAC Basic Information
Table 116. IVAC Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 117. IVAC Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. IVAC Business Overview
Table 119. IVAC Recent Developments
Table 120. Queen Saovabha Mem. Inst Basic Information
Table 121. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 122. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Queen Saovabha Mem. Inst Business Overview
Table 124. Queen Saovabha Mem. Inst Recent Developments
Table 125. Microgen Basic Information
Table 126. Microgen Tuberculosis Prevention and Treatment Vaccine Product Overview
Table 127. Microgen Tuberculosis Prevention and Treatment Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Microgen Business Overview
Table 129. Microgen Recent Developments
Table 130. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 131. Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 133. North America Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 135. Europe Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 137. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 139. South America Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 143. Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Tuberculosis Prevention and Treatment Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 145. Global Tuberculosis Prevention and Treatment Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 146. Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Tuberculosis Prevention and Treatment Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tuberculosis Prevention and Treatment Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Tuberculosis Prevention and Treatment Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Tuberculosis Prevention and Treatment Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tuberculosis Prevention and Treatment Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Tuberculosis Prevention and Treatment Vaccine Product Life Cycle
Figure 13. Tuberculosis Prevention and Treatment Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Tuberculosis Prevention and Treatment Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Tuberculosis Prevention and Treatment Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Tuberculosis Prevention and Treatment Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Tuberculosis Prevention and Treatment Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Tuberculosis Prevention and Treatment Vaccine
Figure 19. Global Tuberculosis Prevention and Treatment Vaccine Market PEST Analysis
Figure 20. Global Tuberculosis Prevention and Treatment Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Type
Figure 27. Sales Market Share of Tuberculosis Prevention and Treatment Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Tuberculosis Prevention and Treatment Vaccine by Type in 2025
Figure 29. Market Share of Tuberculosis Prevention and Treatment Vaccine by Type (2020-2025)
Figure 30. Market Share of Tuberculosis Prevention and Treatment Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Application
Figure 33. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application in 2025
Figure 35. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Application (2020-2025)
Figure 36. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Application in 2025
Figure 37. Global Tuberculosis Prevention and Treatment Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region (2020-2025)
Figure 40. North America Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2024
Figure 43. North America Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Tuberculosis Prevention and Treatment Vaccine Market Size by Country in 2024
Figure 45. U.S. Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Tuberculosis Prevention and Treatment Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Tuberculosis Prevention and Treatment Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Tuberculosis Prevention and Treatment Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Tuberculosis Prevention and Treatment Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Tuberculosis Prevention and Treatment Vaccine Market Size by Country in 2024
Figure 55. Germany Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Size by Region in 2024
Figure 68. China Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2024
Figure 80. South America Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Tuberculosis Prevention and Treatment Vaccine Market Size by Country in 2024
Figure 82. Brazil Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Tuberculosis Prevention and Treatment Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Tuberculosis Prevention and Treatment Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Tuberculosis Prevention and Treatment Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Tuberculosis Prevention and Treatment Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Tuberculosis Prevention and Treatment Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Tuberculosis Prevention and Treatment Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Tuberculosis Prevention and Treatment Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Tuberculosis Prevention and Treatment Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tuberculosis Prevention and Treatment Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Tuberculosis Prevention and Treatment Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Tuberculosis Prevention and Treatment Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tuberculosis Prevention and Treatment Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Tuberculosis Prevention and Treatment Vaccine Product Life Cycle
Figure 13. Tuberculosis Prevention and Treatment Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Tuberculosis Prevention and Treatment Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Tuberculosis Prevention and Treatment Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Tuberculosis Prevention and Treatment Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Tuberculosis Prevention and Treatment Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Tuberculosis Prevention and Treatment Vaccine
Figure 19. Global Tuberculosis Prevention and Treatment Vaccine Market PEST Analysis
Figure 20. Global Tuberculosis Prevention and Treatment Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Type
Figure 27. Sales Market Share of Tuberculosis Prevention and Treatment Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Tuberculosis Prevention and Treatment Vaccine by Type in 2025
Figure 29. Market Share of Tuberculosis Prevention and Treatment Vaccine by Type (2020-2025)
Figure 30. Market Share of Tuberculosis Prevention and Treatment Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Application
Figure 33. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application in 2025
Figure 35. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Application (2020-2025)
Figure 36. Global Tuberculosis Prevention and Treatment Vaccine Market Share by Application in 2025
Figure 37. Global Tuberculosis Prevention and Treatment Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region (2020-2025)
Figure 40. North America Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2024
Figure 43. North America Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Tuberculosis Prevention and Treatment Vaccine Market Size by Country in 2024
Figure 45. U.S. Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Tuberculosis Prevention and Treatment Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Tuberculosis Prevention and Treatment Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Tuberculosis Prevention and Treatment Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Tuberculosis Prevention and Treatment Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Tuberculosis Prevention and Treatment Vaccine Market Size by Country in 2024
Figure 55. Germany Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Size by Region in 2024
Figure 68. China Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country in 2024
Figure 80. South America Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Tuberculosis Prevention and Treatment Vaccine Market Size by Country in 2024
Figure 82. Brazil Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Tuberculosis Prevention and Treatment Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Tuberculosis Prevention and Treatment Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Tuberculosis Prevention and Treatment Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Tuberculosis Prevention and Treatment Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Tuberculosis Prevention and Treatment Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Tuberculosis Prevention and Treatment Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Tuberculosis Prevention and Treatment Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Tuberculosis Prevention and Treatment Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Tuberculosis Prevention and Treatment Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Tuberculosis Prevention and Treatment Vaccine Market Share Forecast by Application (2026-2035)
